A new study in Clinical Epidemiology and Global Health features the Glivec®Patient Assistance Program (GIPAP) and reveals that “chronic myelocytic leukemia (CML) is diagnosed at an earlier age in poorer populations than in more affluent populations.” The study focused on India’s CML population to investigate other possible contributors to early age at onset. The team of authors include our very own South Asia Region Head Viji Venkatesh, and Max CEO Pat Garcia-Gonzalez, as well as Paul H. Levine, Kunal Ajmera, Brenna O’Neill, Heather J. Hoffman.
The study is only available to the public for a limited time so if you know a physician or researcher that would benefit from this study, share it today!
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Physicians are an essential part of our work. We partner with more than 500 healthcare professionals who provide cancer treatment in low- and middle-income countries. They volunteer to be in our program, caring for people in need on top of their regular schedule. Dr. Mipsang Lama is a perfect example – he goes above and….
For the 20th anniversary of World Cancer Day, we asked our global team members, physicians, patients, caregivers, and advocates to share what progress in cancer care means to them. Progress means all cancer patients get the treatment they deserve.[/e World Cancer Day, celebrated on February 4, is a global initiative that aims to raise awareness….
For many patients, there aren’t many opportunities for them to learn about their disease directly from experts. So when the opportunity to hear from a hematologist at Naresuan University Hospital in Thailand, we were excited to maximize the event.
